AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
GONADORELIN
5 registrations across 4 African markets— 5 active
Markets with GONADORELIN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| FERTAGYL Suspension for Injection | 🇿🇲Zambia | Intervet South Africa (Pty) Ltd | active | Apr 2031 |
| Gonasyn | 🇿🇦South Africa | Zoetis South Africa (Pty) Ltd | active | Dec 2029 |
| FERTAGYL INJECTABLE; INJECTION | 🇿🇼Zimbabwe | INTERVET S.A (PTY) LTD | active | Dec 2027 |
| CYSTORELIN | 🇿🇦South Africa | Ceva Animal Health (Pty) Ltd | active | Jan 1900 |
| CYSTORELIN Solution for injection | 🇹🇿Tanzania | Ceva Sante Animale | active | — |
GONADORELIN in Africa — Regulatory Overview
GONADORELIN is registered across 4 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tanzania, Zambia, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 5 registrations, 5 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.